# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025, Regulation 21: Amendment of Schedule 1


(1) Schedule 1 (fees for clinical investigations) is amended as follows.
(2) In Table 1 (clinical investigation of a class I device, class IIa device or class IIb device, which is neither an implantable device nor a long-term invasive device), in the second column (fee)—
(a) in entry 1, for “£7,472” substitute “£15,309”;
(b) in entry 2, for “£5,711” substitute “£11,701”;
(c) in entry 3, for “£207” substitute “£226”.
(3) In Table 2 (clinical investigation of a class IIb device, which is either an implantable device or a long-term invasive device, or a class III device), in the second column (fee)—
(a) in entry 1, for “£15,627” substitute “£32,016”;
(b) in entry 2, for “£11,069” substitute “£22,678”;
(c) in entry 3, for “£331” substitute “£361”.

---
Source: https://www.legislation.gov.uk/ukdsi/2025/9780348270983/regulation/21 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/regulation-21
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

